TCA
Trifecta Capital Advisors’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.3M | Buy |
24,781
+2,712
| +12% | +$2.11M | 3.22% | 7 |
|
2025
Q1 | $18.2M | Sell |
22,069
-74
| -0.3% | -$61.1K | 3.82% | 7 |
|
2024
Q4 | $17.1M | Buy |
22,143
+196
| +0.9% | +$151K | 3.38% | 9 |
|
2024
Q3 | $19.4M | Buy |
21,947
+131
| +0.6% | +$116K | 4.07% | 8 |
|
2024
Q2 | $19.8M | Buy |
21,816
+298
| +1% | +$270K | 4.37% | 7 |
|
2024
Q1 | $16.7M | Sell |
21,518
-1,804
| -8% | -$1.4M | 4.07% | 8 |
|
2023
Q4 | $13.6M | Sell |
23,322
-2,463
| -10% | -$1.44M | 3.76% | 8 |
|
2023
Q3 | $13.8M | Buy |
25,785
+720
| +3% | +$387K | 4.45% | 5 |
|
2023
Q2 | $11.8M | Sell |
25,065
-1,873
| -7% | -$878K | 3.78% | 7 |
|
2023
Q1 | $9.25M | Buy |
26,938
+275
| +1% | +$94.4K | 3.26% | 8 |
|
2022
Q4 | $9.75M | Buy |
+26,663
| New | +$9.75M | 3.89% | 7 |
|